Stevanato Group SpA (STVN) NPV

Sell:$19.51Buy:$21.48$0.43 (2.10%)

Prices delayed by at least 15 minutes
Sell:$19.51
Buy:$21.48
Change:$0.43 (2.10%)
Prices delayed by at least 15 minutes
Sell:$19.51
Buy:$21.48
Change:$0.43 (2.10%)
Prices delayed by at least 15 minutes

Company Information

About this company

Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.

Key people

Franco Stevanato
Executive Chairman of the Board, Chief Executive Officer
Marco Stevanato
Vice Chairman of the Board
Marco Dal Lago
Chief Financial Officer
Riccardo Butta
President, Americas
Ugo Gay
Chief Operations Officer
Mauro Stocchi
Chief Business Officer
Sergio Stevanato
Emeritus Chairman
Karen Flynn
Director
Franco Moro
Director
Luciano Santel
Director
Alvise Spinazzi
Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Italy
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    IT0005452658
  • Market cap
    $6.17bn
  • Employees
    5,635
  • Shares in issue
    49.60m
  • Exchange
    New York Stock Exchange
  • Index
    TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.